oneplacenewsSource: ScienceDaily Health
Summary
Researchers have discovered a vitamin B12 compound that targets glioblastoma tumors effectively in animal studies. This therapy not only enhances existing treatments but also delivers nitric oxide directly to the cancer cells.
Why It Matters
This breakthrough represents a promising advancement in glioblastoma treatment, a notoriously aggressive and deadly brain cancer. The ability of the vitamin B12 compound to cross the blood-brain barrier and improve the efficacy of current therapies could lead to more effective treatment options for patients, potentially improving outcomes in a challenging field of oncology.
